Iodine Seed−Marking Protocol for Response-Guided Axillary Treatment After Systemic Therapy for Node-Positive Breast Cancer
This cohort study found that response-guided axillary treatment, using the MARI protocol, in patients with limited nodal disease who received PST was associated with a very low risk of axillary recurrence and should be considered to protect patients from axillary overtreatment.
Authors
- Nicola S. Russell (ORCID: https://orcid.org/0000-0003-3507-9620)
- Ariane A. van Loevezijn (ORCID: https://orcid.org/0000-0001-8831-4634)
- Vincent van der Noort (ORCID: https://orcid.org/0000-0002-4910-4535)
- Marie-Jeanne T. F. D. Vrancken Peeters (ORCID: https://orcid.org/0000-0003-4472-4257)
- Gabe S. Sonke (ORCID: https://orcid.org/0000-0001-8088-9628)
- Marcel P. M. Stokkel (ORCID: https://orcid.org/0000-0002-8131-5690)
- Annemiek K. E. van Hemert (ORCID: https://orcid.org/0000-0001-9230-9408)
- Claudette E. Loo (ORCID: https://orcid.org/0000-0001-8155-7051)
- Frederieke van Duijnhoven (ORCID: https://orcid.org/0000-0003-3694-4049)
- Emma J. Groen
- Marie-Sophie P. D. Baas
Institutions
- The Netherlands Cancer Institute (NL)
- Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1001/jamaoncol.2025.2752
- Citations
- 6
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.62